From: Tenofovir substitution in Namibia based on an analysis of the antiretroviral dispensing database
Period (Years) | Number (percentage) of patients started on ART | Comparison between females and males: Number (Percentage: confidence interval of patients changed from TDF | ||||
---|---|---|---|---|---|---|
Total (N) | Female: n (%) | Male: n (%) | Female | Male | p-value | |
2008 | 2,898 | 1,642 (56.7) | 1,256 (43.3) | 18 (1.1: 0.6 – 1.6) | 5 (0.4: -0.1 – 0.9) | 0.03 |
2009 | 3,536 | 1,889 (53.4) | 1,647 (46.6) | 32 (1.7: 1.1 – 2.3) | 18 (1.1: 0.5 – 1.7) | 0.13 |
2010 | 8,666 | 5,100 (58.9) | 3,566 (41.1) | 71 (1.4: 0.9 – 1.9) | 70 (1.9: 1.7 – 2.6) | 0.01 |
2011 | 17,101 | 10,465 (61.2) | 6,636 (38.8) | 89 (0.8: 0.5 – 1.1) | 77 (1.2: 0.9 – 1.5) | 0.01 |
TOTAL | 32,129 | 19,096 (59.4) | 13,033 (40.6) | 210 (1.1: 0.9 – 1.3) | 170 (1.3: 1.1 – 1.5) | 0.11 |